82717-96-2: Enalapril EP Impurity B

82717-96-2: Enalapril EP Impurity B

Enalapril EP Impurity B or Ramipril EP Impurity F / Quinapril EP Impurity B / Spirapril EP Impurity C / Moexipril Related Ccompound F / Enalaprilat EP Impurity F (CAS No.82717-96-2) or ((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanine. Enalapril is a prodrug that is hydrolyzed after absorption to form the active angiotensin-converting enzyme Enalaprilat. It is administered orally. It decreases blood pressure by lowering peripheral resistance without increasing heart rate. It is well tolerated an

Additional information on CAS 82717-96-2

Catalogue No.

VL1360002
CAS No.

82717-96-2
Molecular Formula

C15H21NO4
Molecular Weight

279.33
Parent drug

Enalapril
IUPAC Name

((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanine
Synonyms

Ramipril EP Impurity F; Quinapril EP Impurity B; Spirapril EP Impurity C; Moexipril Related Compound F; Enalaprilat EP Impurity F; Trandolapril ECPPA Impurity; (?S)-?-[[(1S)-1-carboxyethyl]amino]benzenebutanoic Acid; N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine;
References

"Davies, Richard O., et al. “Enalapril Worldwide Experience.” The American Journal of Medicine, vol. 77, no. 2, Aug. 1984, pp. 23–35, https://doi.org/10.1016/s0002-9343(84)80055-8. ?Todd, Peter A., and Karen L. Goa. “Enalapril.” Drugs, vol. 43, no. 3, Mar. 1992, pp. 346–81, https://doi.org/10.2165/00003495-199243030-00005. ?"
Status

In-stock

Other products related to enalapril

[rfq_list]

Login first to add product to RFQ List

Request a quote

82717-96-2: Enalapril EP Impurity B

82717-96-2: Enalapril EP Impurity B
Catalogue No.

VL1360002
CAS No.

82717-96-2
Molecular Formula

C15H21NO4
Molecular Weight

279.33
Parent drug

Enalapril
IUPAC Name

((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanine
Synonyms

Ramipril EP Impurity F; Quinapril EP Impurity B; Spirapril EP Impurity C; Moexipril Related Compound F; Enalaprilat EP Impurity F; Trandolapril ECPPA Impurity; (?S)-?-[[(1S)-1-carboxyethyl]amino]benzenebutanoic Acid; N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine;
References

"Davies, Richard O., et al. “Enalapril Worldwide Experience.” The American Journal of Medicine, vol. 77, no. 2, Aug. 1984, pp. 23–35, https://doi.org/10.1016/s0002-9343(84)80055-8. ?Todd, Peter A., and Karen L. Goa. “Enalapril.” Drugs, vol. 43, no. 3, Mar. 1992, pp. 346–81, https://doi.org/10.2165/00003495-199243030-00005. ?"
Status

In-stock
ListName

Enalapril EP Impurity B
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden